{rfName}
Do

Indexed in

License and Use

Icono OpenAccess

Altmetrics

Analysis of institutional authors

Fernandez-Juarez, GemaAuthor

Share

December 24, 2025
Publications
>
Article

Documento de consenso del Grupo de Estudio de Enfermedades Glomerulares de la Sociedad Espanola de Nefrologia (GLOSEN) para el diagnostico y tratamiento de la nefritis lupica

Publicated to: Nefrologia. 43 (1): 6-47 - 2023-02-01 43(1), DOI: 10.1016/j.nefro.2022.10.005

Authors:

Rojas-Rivera, JE; García-Carro, C; Avila, AI; Espino, M; Espinosa, M; Fernández-Juárez, G; Fulladosa, X; Goicoechea, M; Macía, M; Morales, E; Porras, LFQ; Praga, M
[+]

Affiliations

Hosp Clin Barcelona, Serv Nefrol, Barcelona, Spain - Author
Hosp Dr Peset, Serv Nefrol, Valencia, Spain - Author
Hosp Univ 12 Octubre, Serv Nefrol, Madrid, Spain - Author
Hosp Univ Bellvitge, Serv Nefrol, Barcelona, Spain - Author
Hosp Univ Clin San Carlos, Serv Nefrol, Madrid, Spain - Author
Hosp Univ Fdn Jimenez Diaz, Serv Nefrol & Hipertens, Madrid, Spain - Author
Hosp Univ Gregorio Maranon, Serv Nefrol, Madrid, Spain - Author
Hosp Univ La Paz, Serv Nefrol, Madrid, Spain - Author
Hosp Univ Nuestra Senora Candelaria, Serv Nefrol, Tenerife, Spain - Author
Hosp Univ Reina Sofia, Serv Nefrol, Cordoba, Spain - Author
Inst Invest Hosp Univ 12 Octubre, Serv Nefrol, Madrid, Spain - Author
Univ Autonoma Madrid, Dept Med, Serv Nefrol, Madrid, Spain - Author
Univ Barcelona, Dept Med, Serv Nefrol, IDIBAPS, Barcelona, Spain - Author
Univ Complutense, Dept Med, Serv Nefrol, Madrid, Spain - Author
See more

Abstract

A significant number of patients with systemic lupus erythematosus (between 20% to 60% according to different reported series) develop lupus nephritis in the course of its evolution, which directly influences their quality of life and vital prognosis. In recent years, the grea-ter knowledge about the pathogenesis of systemic lupus and lupus nephritis has allowed relevant advances in the diagnostic approach and treatment of these patients, achieving the development of drugs specifically aimed at blocking key pathogenic pathways of the disease. Encouragingly, these immunomodulatory agents have shown in well-powered, randomized clinical trials good clinical efficacy in the medium-term, defined as proteinuria remission and preservation of kidney function, with an acceptable safety profile and good patient tole-rability. All this has made it possible to reduce the use of corticosteroids and other potentially more toxic therapies, as well as to increase the use of combined therapies. The present con-sensus document carried out by the Glomerular Diseases Working Group of the Spanish Society of Nephrology (GLOSEN), collects in a practical and summarized, but rigorous way, the best currently available evidence about the diagnosis, treatment, and follow-up of lupus nephritis patients, including cases of special situations, with the main objective of providing updated information and well-founded clinical recommendations to treating physicians, to improve the diagnostic and therapeutic approach to our patients. & COPY; 2022 Sociedad Espanola de Nefrologi & PRIME;a. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/ by-nc-nd/4.0/).
[+]

Keywords

Biological therapyChronic kidney-diseaseControlled-trialImmunosupressive treatmentIntravenous cyclophosphamideKidney biopsyLupus nephritisMaintenance therapyMultitarget therapyMycophenolate-mofetilNephrotic syndromePulse cyclophosphamideRenal outcomesRenin-angiotensin systemStage renal-diseaseSystemic-lupus-erythematosus

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Nefrologia due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2023, it was in position 61/126, thus managing to position itself as a Q2 (Segundo Cuartil), in the category Urology & Nephrology. Notably, the journal is positioned en el Cuartil Q3 para la agencia Scopus (SJR) en la categoría Nephrology.

Independientemente del impacto esperado determinado por el canal de difusión, es importante destacar el impacto real observado de la propia aportación.

Según las diferentes agencias de indexación, el número de citas acumuladas por esta publicación hasta la fecha 2026-04-04:

  • Dialnet Métricas: 2
  • WoS: 2
[+]

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2026-04-04:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 101.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 101 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 43.
  • The number of mentions on the social network X (formerly Twitter): 67 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.
  • Additionally, the work has been submitted to a journal classified as Diamond in relation to this type of editorial policy.
[+]

Leadership analysis of institutional authors

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (Rojas-Rivera, Jorge E) .

the author responsible for correspondence tasks has been Rojas-Rivera, Jorge E.

[+]